key trials in ctcl
Published 2 years ago • 49 plays • Length 1:57Download video MP4
Download video MP3
Similar videos
-
0:45
key trials in cll and designing a concept for treatment
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:12
key emerging trials in cml and the importance of improving treatment-free remission rates
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
2:51
key btk inhibitor trials for the initial treatment of cll
-
3:19
key clinical trials in mds taking place in the us
-
32:56
clinical case presentation - j. kellum
-
1:55
the evolving role of venetoclax in cll
-
8:32
chronic lymphocytic leukemia (cll) - etiology, risk factors, symptoms, signs, diagnosis, treatment
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
8:57
outcomes of sct in t-all and t-lbl
-
1:56
investigating linvoseltamab monotherapy in smm: the linker-smm1 trial
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
3:21
long-term outcomes from key clinical trials presented at ash 2023
-
0:55
multimarker approach to ctc analysis in ctcl
-
1:33
key factors affecting treatment decision making in cll
-
2:25
key ebmt guideline updates for the treatment and prophylaxis of gvhd
-
6:48
key trials in multiple myeloma presented at ash 2023: take home messages
-
1:44
the impact of acalabrutinib treatment by line of therapy in patients with cll
-
3:10
is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?